Advancing sepsis care through collaboration and innovation

Sepsis remains one of the most urgent challenges in modern healthcare, affecting millions of people worldwide each year and contributing to significant morbidity and mortality. While advances in diagnostics, therapeutics, and critical care have improved outcomes for many patients, the complexity of sepsis continues to present major clinical and operational challenges. Increasingly, experts believe meaningful progress will depend not only on scientific innovation but also on stronger collaboration across the healthcare ecosystem.

The diagnosis and management of sepsis require rapid decision-making in situations where every hour can affect patient outcomes. However, sepsis is a highly heterogeneous condition, with patients presenting differently depending on the underlying infection, host response, age, comorbidities, and disease progression. This variability has made it difficult to develop universal approaches to diagnosis and treatment, highlighting the need for new strategies that can better reflect the biological complexity of the condition.

In this SelectScience® CLINICAL24 Forum, presented in partnership with Danaher, attendees will hear from leading experts in infectious disease, critical care medicine, and patient advocacy as they explore how collaborative approaches are driving progress in sepsis care. The discussion will focus on the importance of bringing together expertise from academia, healthcare organizations, industry, and patient advocacy groups to accelerate innovation and improve patient outcomes.

A key focus of the forum will be the growing interest in sepsis subtyping and precision medicine approaches. Researchers are increasingly seeking to understand why patients respond differently to infection and how biological signatures may help identify distinct sepsis subgroups. Improved understanding of these variations could help support more personalized approaches to diagnosis, monitoring, and treatment in the future.

The panel will also examine the role of multi-stakeholder partnerships in advancing sepsis research and clinical practice. From large-scale research initiatives and clinical trials to educational programs and public awareness campaigns, collaboration has become an essential component of efforts to improve sepsis recognition, management, and outcomes. By combining scientific expertise, clinical insight, and patient perspectives, organizations can address challenges that no single group can solve alone.

Attendees will gain valuable insight into lessons learned from successful partnerships across healthcare and research communities. The discussion will highlight how collaboration can help accelerate innovation, generate meaningful data, improve adoption of new approaches, and ultimately support better care for patients at risk of sepsis.

For clinical laboratory professionals, clinicians, researchers, healthcare leaders, and diagnostics specialists, this forum provides an opportunity to explore some of the most important developments shaping the future of sepsis care. Through expert-led discussion and real-world perspectives, participants will gain a deeper understanding of how innovation and collaboration can work together to address one of healthcare's most complex challenges.

Live attendees will automatically receive a certificate of attendance, including a summary of key learning outcomes, making this session a valuable opportunity for continuing professional development.